CN102439139A - 癌组织来源细胞块及其制备方法 - Google Patents
癌组织来源细胞块及其制备方法 Download PDFInfo
- Publication number
- CN102439139A CN102439139A CN2010800099623A CN201080009962A CN102439139A CN 102439139 A CN102439139 A CN 102439139A CN 2010800099623 A CN2010800099623 A CN 2010800099623A CN 201080009962 A CN201080009962 A CN 201080009962A CN 102439139 A CN102439139 A CN 102439139A
- Authority
- CN
- China
- Prior art keywords
- cancerous tissue
- derived cell
- tissue derived
- cell piece
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (19)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009-048478 | 2009-03-02 | ||
JP2009048478 | 2009-03-02 | ||
JP2009-228536 | 2009-09-30 | ||
JP2009228536A JP5652809B2 (ja) | 2009-03-02 | 2009-09-30 | 癌組織由来細胞塊およびその調製法 |
PCT/JP2010/053253 WO2010101119A1 (ja) | 2009-03-02 | 2010-03-01 | 癌組織由来細胞塊およびその調製法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102439139A true CN102439139A (zh) | 2012-05-02 |
Family
ID=42709676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010800099623A Pending CN102439139A (zh) | 2009-03-02 | 2010-03-01 | 癌组织来源细胞块及其制备方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20120164732A1 (zh) |
EP (1) | EP2412803B1 (zh) |
JP (1) | JP5652809B2 (zh) |
CN (1) | CN102439139A (zh) |
CA (1) | CA2753526C (zh) |
SG (2) | SG174224A1 (zh) |
WO (1) | WO2010101119A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104931317A (zh) * | 2015-06-11 | 2015-09-23 | 宁波美晶医疗技术有限公司 | 一种血液前处理液 |
CN107151645A (zh) * | 2017-05-16 | 2017-09-12 | 武汉大学深圳研究院 | 一种为肺癌提供离体个体化药物测试的方法及培养基 |
CN110475860A (zh) * | 2017-03-16 | 2019-11-19 | 美迪恩斯生命科技株式会社 | 使用肿瘤组织的原代癌细胞的三维培养 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5652809B2 (ja) | 2009-03-02 | 2015-01-14 | 株式会社ルネッサンス・エナジー・インベストメント | 癌組織由来細胞塊およびその調製法 |
JP5809782B2 (ja) * | 2009-12-24 | 2015-11-11 | 株式会社ルネッサンス・エナジー・インベストメント | 癌組織由来細胞塊または癌細胞凝集塊の薬剤または放射線感受性評価方法 |
US20130012404A1 (en) * | 2010-01-19 | 2013-01-10 | Osaka Prefectural Hospital Organization | Culture method, evaluation method and storage method for cancer-tissue-derived cell mass or aggregated cancer cell mass |
KR20130024904A (ko) * | 2010-05-26 | 2013-03-08 | 지방독립 행정법인 오사카 부립 병원 기구 | 암 조직 유래 세포괴 또는 암 세포 응집괴의 약제 또는 방사선 감수성 평가 방법 |
EP3208331A1 (en) * | 2016-02-17 | 2017-08-23 | PromoCell bioscience alive GmbH Biomedizinische Produkte | Chemically defined medium for the culture of cancer stem cell (csc) containing cell populations |
JP6719769B2 (ja) | 2016-07-22 | 2020-07-08 | 地方独立行政法人 大阪府立病院機構 | 初代細胞培養法 |
EP3674394A4 (en) | 2017-08-21 | 2021-05-26 | Toppan Printing Co., Ltd. | PRIMARY CULTURE PROCESS |
AU2019440405A1 (en) | 2019-04-11 | 2021-12-09 | Genex Health Co., Ltd | Method for culturing primary cells of gastric cancer and gallbladder and bile duct cancer, and supporting reagents |
CN112322586A (zh) * | 2020-11-05 | 2021-02-05 | 广州元信生物科技有限公司 | 一种肿瘤组织消化液及其方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1336431A (zh) * | 2001-08-23 | 2002-02-20 | 北京大学人民医院 | 人卵巢癌永生化细胞株的建立 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2622700B1 (fr) | 1987-10-30 | 1993-08-13 | Aderegem | Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein |
JP4734739B2 (ja) | 2000-09-29 | 2011-07-27 | 東レ株式会社 | 哺乳動物のガン抑制方法 |
EP1539247A4 (en) | 2002-07-16 | 2007-08-29 | Univ New Jersey Med | ALPHA 5 BETA 1 AND ITS ABILITY TO REGULATE THE CELL SURVIVAL PATH |
EP1783205B1 (en) | 2004-06-18 | 2024-02-21 | Riken | Method of inducing the differentiation of embryonic stem cells into nerve by serum-free suspension culture |
WO2006129735A1 (ja) | 2005-05-31 | 2006-12-07 | Olympus Corporation | 遺伝子導入細胞及び細胞分析方法 |
ATE555215T1 (de) | 2005-06-27 | 2012-05-15 | Wayne John Cancer Inst | Molekulare/genetische aberrationen in chirurgischen rändern von pankreaskrebsresektionen stellen eine neoplastische erkrankung dar, die mit dem resultat korreliert |
JP2011193728A (ja) | 2008-07-17 | 2011-10-06 | Murata Mfg Co Ltd | EpCAMに結合能を有するペプチド |
JP5652809B2 (ja) | 2009-03-02 | 2015-01-14 | 株式会社ルネッサンス・エナジー・インベストメント | 癌組織由来細胞塊およびその調製法 |
US20130012404A1 (en) | 2010-01-19 | 2013-01-10 | Osaka Prefectural Hospital Organization | Culture method, evaluation method and storage method for cancer-tissue-derived cell mass or aggregated cancer cell mass |
-
2009
- 2009-09-30 JP JP2009228536A patent/JP5652809B2/ja active Active
-
2010
- 2010-03-01 SG SG2011063385A patent/SG174224A1/en unknown
- 2010-03-01 US US13/254,162 patent/US20120164732A1/en not_active Abandoned
- 2010-03-01 WO PCT/JP2010/053253 patent/WO2010101119A1/ja active Application Filing
- 2010-03-01 EP EP10748714.2A patent/EP2412803B1/en active Active
- 2010-03-01 CA CA2753526A patent/CA2753526C/en active Active
- 2010-03-01 CN CN2010800099623A patent/CN102439139A/zh active Pending
- 2010-03-01 SG SG2014012843A patent/SG2014012843A/en unknown
-
2014
- 2014-03-31 US US14/231,278 patent/US8841125B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1336431A (zh) * | 2001-08-23 | 2002-02-20 | 北京大学人民医院 | 人卵巢癌永生化细胞株的建立 |
Non-Patent Citations (4)
Title |
---|
R. PADUCH: "Vitamin D, tamoxifen and β-estradiol modulate breast cancer cell growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium", 《CELL BIOLOGY AND TOXICOLOGY》, 31 December 2005 (2005-12-31) * |
RICHARD HERRMANN: "Screening for Compounds That Induce Apoptosis of Cancer Cells Grown as Multicellular Spheroids", 《JOURNAL OF BIOMOLECULAR SCREENING》, vol. 13, no. 1, 31 December 2008 (2008-12-31), XP002694232, DOI: 10.1177/1087057107310442 * |
王海霞: "小肠上皮细胞分离纯化方法的研究进展", 《中国畜牧杂志》, vol. 44, no. 1, 31 December 2008 (2008-12-31), pages 55 * |
邢虎: "影响喉癌组织原代培养成功率因素的研究", 《首都医科大学学报》, vol. 26, no. 3, 30 June 2005 (2005-06-30) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104931317A (zh) * | 2015-06-11 | 2015-09-23 | 宁波美晶医疗技术有限公司 | 一种血液前处理液 |
CN110475860A (zh) * | 2017-03-16 | 2019-11-19 | 美迪恩斯生命科技株式会社 | 使用肿瘤组织的原代癌细胞的三维培养 |
CN110475860B (zh) * | 2017-03-16 | 2024-05-14 | 美迪恩斯生命科技株式会社 | 使用肿瘤组织的原代癌细胞的三维培养 |
CN107151645A (zh) * | 2017-05-16 | 2017-09-12 | 武汉大学深圳研究院 | 一种为肺癌提供离体个体化药物测试的方法及培养基 |
Also Published As
Publication number | Publication date |
---|---|
WO2010101119A1 (ja) | 2010-09-10 |
EP2412803A4 (en) | 2013-05-01 |
US20120164732A1 (en) | 2012-06-28 |
SG174224A1 (en) | 2011-10-28 |
US8841125B2 (en) | 2014-09-23 |
EP2412803B1 (en) | 2015-11-11 |
US20140227781A1 (en) | 2014-08-14 |
CA2753526C (en) | 2015-08-25 |
EP2412803A1 (en) | 2012-02-01 |
SG2014012843A (en) | 2014-08-28 |
CA2753526A1 (en) | 2010-09-10 |
JP2010227088A (ja) | 2010-10-14 |
JP5652809B2 (ja) | 2015-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102439139A (zh) | 癌组织来源细胞块及其制备方法 | |
Bahmad et al. | Sphere-formation assay: three-dimensional in vitro culturing of prostate cancer stem/progenitor sphere-forming cells | |
Klein et al. | Glioblastoma organoids: pre-clinical applications and challenges in the context of immunotherapy | |
Lang et al. | Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours | |
WO2011068183A1 (ja) | 癌細胞凝集塊およびその調製法 | |
CN103328626B (zh) | 癌干细胞群及其制备方法 | |
CN102203290B (zh) | 肿瘤干细胞分子标记 | |
WO2011090068A1 (ja) | 癌組織由来細胞塊または癌細胞凝集塊の培養方法、評価方法および保存方法 | |
WO2011149013A1 (ja) | 癌組織由来細胞塊または癌細胞凝集塊の薬剤または放射線感受性評価方法 | |
Martignani et al. | Human milk protein production in xenografts of genetically engineered bovine mammary epithelial stem cells | |
CN101855339A (zh) | 人类癌症干细胞 | |
US20080008999A1 (en) | Process for detecting the existence of mesenchymal chrondrosarcoma | |
CN102250840A (zh) | 一种人胰腺癌细胞系及其应用 | |
Karikari et al. | Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines | |
CN104031884B (zh) | 蛋白质精氨酸甲基转移酶7在癌细胞转移中的应用 | |
CN105229027A (zh) | Nme抑制剂以及应用nme抑制剂的方法 | |
Barnett et al. | Studies of mammary carcinoma metastasis in a mouse model system. I: Derivation and characterization of cells with different metastatic properties during tumour progression in vivo | |
CN114717190A (zh) | 一种人乳腺恶性叶状肿瘤细胞系bpt0713及其应用 | |
CN107541497B (zh) | 人垂体腺瘤细胞株及其用途 | |
CN113322227B (zh) | 基于微针的睾丸组织体外培养方法及其应用 | |
CN107460170B (zh) | 人垂体腺瘤细胞系的建立及其应用 | |
CN105764334A (zh) | 加强肿瘤生长的方法 | |
KR20130055591A (ko) | 암 조직 유래 세포괴 또는 암 세포 응집괴로부터 얻어지는 암 치료용 조성물과 그것을 이용한 면역요법제의 제조 방법 및 면역요법 효과 평가 방법 | |
US20210038688A1 (en) | Icam-1 marker and application thereof | |
Doberstein et al. | Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: RENESENSE ENERGY INVESTMENT CO., LTD. Free format text: FORMER OWNER: REI MEDICAL CO., LTD. Effective date: 20120918 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120918 Address after: Kyoto Japan Applicant after: Ruinaisensi Energy Investment Co. Ltd. Applicant after: Osaka Prefectural Hospital Org Address before: Japan, Kyoto Kyoto Imperial Mausoleum Taiyuan 1-39 Xijing area (6158245) Applicant before: Rei Medical Co. Ltd Applicant before: Osaka Prefectural Hospital Org |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Hyogo Applicant after: Ruinaisensi Energy Investment Co. Ltd. Applicant after: Osaka Prefectural Hospital Org Address before: Kyoto Japan Applicant before: Ruinaisensi Energy Investment Co. Ltd. Applicant before: Osaka Prefectural Hospital Org |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120502 |